CAPA E Newsletter

CAPA E Newsletter

CAPA e Newsletter Chinese American Pathologists Association ~ 全美华人病理学会 ~ volume 5 issue 1 2019 In this issue: A Note from P1-2 A Note from President President New Board of Direc- P2 tors (BOD) (2019- sponsor money to support our annual 2021) ear meeting. Finance committee, especially CAPA Annual Busi- P3 CAPA the chair Dr. Huihong Xu, has done ness Meeting and members, extensive work handling the paperwork Scientific Session th D and planning the CAPA annual meeting. (March 16 , 2019) Happy Chinese New We are looking forward to more 2019 CAPA-GoPath P4-5 Best Abstract Award Year! volunteers’ participation in meeting Winners logistics. Time flies. I believe CAPA Online Educa- P6 tion Meeting that this is going to be Award Committee, led by Dr. Xiuli Liu, the last issue of newsletter in my term. Thank has successfully completed the abstract Online Education P7-9 Topics, Schedule and Dr. Fan Chen and her eNewsletter Committee calling, reviewing, scoring and ranking Speakers for their beautiful work as always. processes. Thank Xiuli and her team for List of Speakers P10-20 the exceptional job and congratulations to In the last 3 months, with a collective effort the 14 winners. Organizing Group P21 of our committees and each individuals like Support Group P22 you, we achieved much. In this issue, I herein We completed CAPA website redesign and Recent Achievements P20,23 share with you some highlights of what membership re-registration process. The new from CAPA Members happened and going to happen in our society. website allows integration of membership New Pathology Guide- P24 registration with payment and timely update line Advances Accura- th USCAP and the 17 CAPA annual business members’ information. To date, more than cy in Breast Cancer meeting/scientific session are right around 500 people have registered to the new Testing the corner. The updated agenda of CAPA system. As far as I know, potential Case of Quarter P25-26 (COQ) meeting is ready for you. It is an important collaborators of other pathologists societies social and educational event and please and sponsors frequently visit our website Private Practice Q&A P26 for CAPA eNewsletter attend if you are able. I am looking forward before making their decisions. Since the to seeing you at the meeting and at the group website is a showcase of CAPA, I encourage Recipes of Quarter P27 dinner on Saturday, March 16, 2019. and welcome your feedbacks to further (ROQ) improve CAPA website. Thank Drs. Acknowledgements P28 Education Committee, led by Drs. Wei Zenggang Pan, Xin Han, Xiangdong Xu, and and Advertisements for CAPA Sponsors Xin and Huan-You Wang, has nicely their website/membership team for the organized two-hour scientific session in excellent job. the CAPA annual meeting. Thank Wei and Huan-You and their team as well as During January 4-6, 2019, we had an all the speakers. We are looking forward election for CAPA Board of Directors to the lectures. (BOD). This was the first election for BOD in CAPA history and was conducted Financially, in addition to sponsors from based on the recently amended CAPA GoPath and Motic for the two best Bylaws. abstract awards, we secured $20,500 (Cont’d on Page 2) A Note from President (Cont’d) (Cont’d from Page 1) received and very beneficial to members practicing in both academic and private settings. I am grateful to Dr. Rong More than two thirds of eligible members (>200) cast Fan for his willingness to take over the leadership role of their votes. The election process ran smoothly and online education course. I am fully confident that after a successfully under the supervision of CAPA Election smooth transition, he will bring the online course to a new Committee, chaired by Dr. Youli Zu. Five CAPA level. members have been elected to serve the BOD for the years 2019 to 2021. They are (in alphabetical order): Finally, I would like to express my gratitude to all the EC Drs. Xiaoxian Li (李笑闲), He Wang (王鹤), members for their dedicated work throughout this Haodong Xu (徐浩东), Huihong Xu (徐慧红), and extraordinary year, and to all of you, the CAPA members. It is your trust, encouragement and support that make 周杰昊). Jiehao Zhou ( Congratulations to the five CAPA a vibrant and active society. It is the work of YOU new BOD members! I would like to thank all who are willing to take time from your busy personal and candidates and participants and hope that more professional lives that furthers CAPA mission and ensures members are actively involved in future CAPA its healthy growth. With the new leadership on board and activities. I also would like to thank Dr. Youli Zu and your further support, I am looking forward to a bright his Election Committee team, the IT support team and future ahead of us. the webstie/membership team for the excellent job. Over the last two years, Online Education Subcommittee, Sincerely yours, led by Drs. Zenggang Pan and Linsheng Zhang, did marvelous job in organizing online education courses. I would like to thank all the 62 speakers, 15 organizing group members and 15 supporting group members, for Yun Gong their time, effort and dedication. The lectures covered CAPA President 2018-2019 topics in a variety of subspecialties and all were very well MD Anderson Cancer Center New Board of Directors (BOD) (2019-2021) Xiaoxian (Bill) Li, He Wang, MD, Haodong Xu, Huihong Xu, Jiehao Zhou, MD, MD, PhD (李笑闲) PhD (王鹤) MD, PhD (徐 MD. (徐慧红) PhD ( 周杰昊) Emory University Robert Wood 浩东) Boston VA Indiana Universi- Johnson School University of Health Care ty School of Med- of Medicine, Rut- Washington System icine (IUSM) gers University CAPA Annual Business Meeting and Scientific Session (March 16th, 2019) Cherry Blossom Ballroom at Gaylord National Resort & Convention Center 1:00-1:20 PM Registration 1:20-1:50 PM Presentations by key sponsor(s) 1:50-3:50 PM Scientific session (see attached program), chaired by Drs. Wei Xin and Huan-You Wang Time Title Speakers Institution 1:50-2:10 Histological spectrum of heavily treated, Jiaoti Huang, MD, PhD Duke University metastatic prostatic cancer 2:10-2:30 Fifty shades of pink: New renal oncocytic Ming Zhou, MD, PhD UT Southwestern University tumors 2:30-2:50 Update of melanocytic lesion George Xu, MD, PhD University of Pennsylvanian 2:50-3:10 BK polyomavirus associated urothelial Chin-Lee Wu, MD, PhD Harvard University carcinoma: cellular origin is critically im- portant in this new entity 3:10-3:15 Q&A 3:15-3:25 NK lymphoma on liver biopsy Lijuan Wang, MD, PhD Brown University 3:25-3:35 Interesting FNA cases from a patient’s Zhongren Zhou, MD, Washington University neck and mediastinal lymph nodes PhD 3:35-3:45 A Case of sarcomatoid carcinoma of uri- Chunhua Cui, MD Health Network Labs nary bladder 3:45-3:50 Q&A 3:50-4:30 PM Annual reports including reports from Membership/Website Committee and Finance Committees, general CAPA Award presentation, by Drs. Zenggang Pan, Huihong Xu and Dr. Yun Gong 4:30-4:50 PM CAPA-GoPath and CAPA-Motic Best Abstract Award Session, presented by Dr. Xiuli Liu with GoPath and Motic representatives 4:50-5:00 PM Presentation by the next President Dr. Huan-You Wang 5:00-5:15 PM Speeches by leaders of other Pathology Societies 5:15-5:30 PM Group Pictures 5:30-6:00 PM Bus to the restaurant (Hunan Dynasty, 皇朝) 6:00 PM~ Group dinner (Hunan Dynasty, 215 PENNSYLVANIA AVE SE, WASHINGTON, DC 20003-1155 Tel: 202- 5466161) 2019 CAPA-GoPath Best Abstract Award Winners Award Name Title Institution 1st place Yanjun Hou, MD, Immunohistochemical comparison of metaplas- Cleveland clinic, OH PhD Cytology fel- tic breast carcinoma with triple negative breast low carcinoma lacking metaplastic features in rela- tion to checkpoint immune biomarkers 2nd place Yihe Yang, MD Is Use of Cancer Protocol Templates (CAP Long Island Jewish Medical Resident (PGY2) Synoptics Reports) Associated with Improved Center /Northshore University Cancer Patient Survival? An Exploratory Eco- Hospital, Lake Success, NY logical Study Using Data from the Surveillance, Epidemiology, and End Results (SEER) Pro- gram and Public Searching Engines 2rd place Feng Yin, MD, PhD Splenic arterial involvement is associated with University of Florida, Gaines- Adjunct Clinical poor prognosis in resected distal pancreatic ville, FL Postdoctoral Fellow cancer 3rd place Wei Zheng, MD, OATP1B3 Is A Novel Immunohistochemical UCLA, Los Angeles, CA PhD GI/Liver Marker to Discriminate Well Differentiated Pathology Fellow Hepatocellular Carcinoma from Its Benign Hepatocellular Mimickers 3rd place Lin Zhang, MD The predictive and prognostic value of The University of Texas PhD Resident FOXP3+ and FOXP3+/CD25+ regulatory T Health Science Center at Hou- (PGY3) cells, and PD-L1 expression in triple negative ston, TX breast cancer 3rd place Fengming Chen, Intraoperative diagnosis of signet ring cell car- Penn State Health Milton S. MD, PhD cinoma: an 18-year experience and lesson of a Hershey Medical Center, Her- Resident single institution shey, PA 3rd place Yaohong Wang, Metal Regulatory Transcription Factor 1: An University of Tennessee M.D. Resident Essential Role in Ovarian Cancer Metastasis Health Science Center, Mem- and a Poor Clinical Prognostic Indicator phis, TN 2019 CAPA-Motic Best Abstract Award Winners Award Name Title Institution 1st place Li Zhang Clinicopathological features of Epstein-Barr Peking University Cancer virus infection, microsatellite instability, HER2 Hospital and PD-L1 expression in 2504 Chinese gastric cancer 2nd place Mi-die Xu Prognostic value of DNA repair gene based on Fudan University Shanghai

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    28 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us